Literature DB >> 9168175

Clinical heterogeneity in respiratory chain complex III deficiency in childhood.

J Mourmans1, U Wendel, H A Bentlage, J M Trijbels, J A Smeitink, I F de Coo, F J Gabreëls, R C Sengers, W Ruitenbeek.   

Abstract

Six children are presented with an isolated complex III deficiency in muscle tissue. More specifically, oxidation rates and ATP+CrP production rates from both pyruvate and succinate as substrates and/or the activity of decylubiquinol:cytochrome c oxidoreductase were all markedly reduced. Complex III deficiency was also present in liver of two patients tested, but could not be demonstrated in cultured fibroblasts of four patients tested. Mitochondrial DNA, extracted from muscle, was analyzed; no deletions or common point mutations were found. Four patients presented with a multi-organ disorder. Among these patients three presented at neonatal age with neurological signs and lactate elevation in blood and CSF, of whom two had severe neonatal Fanconi syndrome. One child, aged seven years, had encephalomyopathy, ophthalmoplegia, retinopathy and Wolff-Parkinson-White syndrome. The remaining two patients exhibited myopathy only, within the first year of life. Thus, like in other respiratory chain disorders, patients with complex III deficiency may present at any age and show variable symptoms and outcome, ranging from neonatal death to failure to thrive only. Apparently there are no clinical findings which are specific for complex III deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168175     DOI: 10.1016/s0022-510x(97)05379-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

Review 1.  Functional, structural, and genetic mitochondrial abnormalities in myocardial diseases.

Authors:  A Brega; J Narula; E Arbustini
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

Review 2.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

3.  Infantile Progressive Hepatoencephalomyopathy with Combined OXPHOS Deficiency due to Mutations in the Mitochondrial Translation Elongation Factor Gene GFM1.

Authors:  S Balasubramaniam; Y S Choy; A Talib; M D Norsiah; L P van den Heuvel; R J Rodenburg
Journal:  JIMD Rep       Date:  2011-12-21

4.  UQCRC2 mutation in a patient with mitochondrial complex III deficiency causing recurrent liver failure, lactic acidosis and hypoglycemia.

Authors:  Pauline Gaignard; Didier Eyer; Elise Lebigot; Christophe Oliveira; Patrice Therond; Audrey Boutron; Abdelhamid Slama
Journal:  J Hum Genet       Date:  2017-03-09       Impact factor: 3.172

Review 5.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 6.  Energy metabolism in the normal and failing heart: potential for therapeutic interventions.

Authors:  William C Stanley; Margaret P Chandler
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

7.  A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis.

Authors:  Sandrine Haut; Michèle Brivet; Guy Touati; Pierre Rustin; Sophie Lebon; Angela Garcia-Cazorla; Jean Marie Saudubray; Audrey Boutron; Alain Legrand; Abdelhamid Slama
Journal:  Hum Genet       Date:  2003-04-23       Impact factor: 4.132

8.  Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene.

Authors:  J A Keightley; R Anitori; M D Burton; F Quan; N R Buist; N G Kennaway
Journal:  Am J Hum Genet       Date:  2000-10-20       Impact factor: 11.025

9.  A novel mutation in the mitochondrial DNA cytochrome b gene (MTCYB) in a patient with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes syndrome.

Authors:  Valentina Emmanuele; Evangelia Sotiriou; Purificación Gutierrez Rios; Jaya Ganesh; Rebecca Ichord; A Reghan Foley; H Orhan Akman; Salvatore Dimauro
Journal:  J Child Neurol       Date:  2012-05-25       Impact factor: 1.987

10.  Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake.

Authors:  C I Nabuurs; C U Choe; A Veltien; H E Kan; L J C van Loon; R J T Rodenburg; J Matschke; B Wieringa; G J Kemp; D Isbrandt; A Heerschap
Journal:  J Physiol       Date:  2012-11-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.